Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.
Amphion has a significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.
Amphion also has two specialized entities, MSA Holding, a joint venture intended to replicate the Amphion model in the Gulf, and DataTern, Inc., established to exploit IP opportunities within the Company's Partner Companies.
Amphion Innovations UK, Ltd.
10 Greycoat Place
Westminster
London
SW1P 1SB
UK
©2009 Amphion Innovations plc. • All Rights Reserved